FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2550602693> ?p ?o ?g. }

• W2550602693 abstract "Abstract Background During clotting, factors IXa and VIIa participate in the activation of Factor X, leading to thrombin generation. This process occurs on the surface of activated platelets. Activated platelets release an array of proteins that can modulate thrombin generation. This includes platelet factor 4 (PF4), a chemokine that modulates coagulation by promoting protein C activation and by attenuating the anticoagulant activity of activated protein C. PF4 shares significant homology with another protein released in high concentration by platelets, β-thromboglobulin (βTG). The physiological effects of βTG, including effects on blood coagulation, are poorly characterized. The aim of this study was to assess the effect of βTG on blood coagulation. Methods The effect of purified human βTG on coagulation was determined using the prothrombin time (PT), activated partial thromboplastin time (APTT), calibrated automated thrombography (4µM phospholipids ± 1pM tissue factor (TF)) and chromogenic FX and prothrombin activation assays. Mass spectrometry and surface plasmon resonance (SPR) were used to assess the composition of the purified βTG preparation and to measure protein-protein interactions respectively. Results Mass spectrometry confirmed the absence of TF, FVIIa, FVIIIa, FIXa, FVa, and FXa in the βTG preparation. In normal pooled plasma, βTG dose-dependently increased the rate and extent of TF stimulated thrombin generation. In the absence of βTG, the lagtime was 9±1 min, which was shortened in a dose-dependent manner upon incubation with βTG (100µg/ml; 5±1 min, p<0.05). Incubation with βTG (50µg/ml) also shortened the APTT (35±1 to 25±1 secs, p<0.05) and reduced the lagtime to thrombin generation (26±5 to 7±1 min, p<0.05) and increased the peak thrombin generation (60±30 to 97±23nM, p<0.05) in the absence of an exogenous TF stimulus. Immunodepleted plasmas and inhibitory antibodies were used to determine the underlying mechanism of action. In FVIII-deficient plasma, thrombin generation was not observed in the absence of an exogenous TF stimulus. However, upon incubation with βTG (50µg/ml), thrombin generation was observed and peak thrombin generation increased from 1±1 to 75±12nM IIa (p<0.05). βTG also shortened the APTT in FVIII-deficient plasma from 131±8 to 103±14 secs (50µg/ml, p<0.05). The procoagulant effect of βTG in FVIII-deficient plasma was not inhibited by TF or FVIIa inhibitory antibodies, suggesting that the effect was independent of the intrinsic tenase complex, TF or FVIIa. Interestingly, homologous PF4 did not induce thrombin generation in FVIII-deficient plasma (peak thrombin generation was 75±12nM v 0±0nM IIa upon incubation with 50µg/ml βTG and PF4 respectively). The procoagulant effect of βTG persisted when thrombin generation was independent of FV activation (supplementation of FV-deficient plasma with FVa). In contrast, the effect was not observed when thrombin generation was independent of FX activation (supplementation of FX-deficient plasma with FXa). Collectively, these data raised the possibility that βTG may modulate FX activation. To investigate this hypothesis, chromogenic FX activation was measured. Cleavage of a FXa-specific chromogenic substrate was observed upon incubation of βTG with FX, suggesting a direct effect of βTG upon FX activation. No measurable chromogenic substrate cleavage was observed upon incubation with βTG or FX alone. In contrast, βTG did not induce prothrombin activation, measured using a thrombin-specific chromogenic substrate. Using SPR, βTG was found to bind directly to immobilised FX (KD 1.36±0.7x10-7 M). The kinetics of the interaction between βTG and FX was lower than that between FIXa and FX (KD 4.25±1.90 × 10-9 M). Conclusion In conclusion, we have identified that βTG is a potential novel platelet-derived activator of coagulation FX. Moreover, βTG is capable of inducing thrombin generation in immunodepleted FVIII and FIX-deficient plasma, a finding that may be of translational relevance to patients with haemophilia. Disclosures Ní Áinle: Actelion Pharma: Research Funding; Leo Pharma: Research Funding; Bristol Myers Squibb: Membership on an entity's Board of Directors or advisory committees; Bayer: Membership on an entity's Board of Directors or advisory committees; Daiichi Sankyo: Membership on an entity's Board of Directors or advisory committees; Boehringer Ingelheim: Membership on an entity's Board of Directors or advisory committees." @default.
• W2550602693 created "2016-11-30" @default.
• W2550602693 creator A5002378444 @default.
• W2550602693 creator A5006193076 @default.
• W2550602693 creator A5009337993 @default.
• W2550602693 creator A5040090357 @default.
• W2550602693 creator A5049433254 @default.
• W2550602693 creator A5062217593 @default.
• W2550602693 creator A5065743027 @default.
• W2550602693 creator A5087900103 @default.
• W2550602693 creator A5089308610 @default.
• W2550602693 creator A5091562783 @default.
• W2550602693 date "2015-12-03" @default.
• W2550602693 modified "2023-09-27" @default.
• W2550602693 title "Platelet-Derived Beta Thromboglobulin: A Potential Novel Activator of Coagulation Factor X" @default.
• W2550602693 doi "https://doi.org/10.1182/blood.v126.23.2276.2276" @default.
• W2550602693 hasPublicationYear "2015" @default.
• W2550602693 type Work @default.
• W2550602693 sameAs 2550602693 @default.
• W2550602693 citedByCount "0" @default.
• W2550602693 crossrefType "journal-article" @default.
• W2550602693 hasAuthorship W2550602693A5002378444 @default.
• W2550602693 hasAuthorship W2550602693A5006193076 @default.
• W2550602693 hasAuthorship W2550602693A5009337993 @default.
• W2550602693 hasAuthorship W2550602693A5040090357 @default.
• W2550602693 hasAuthorship W2550602693A5049433254 @default.
• W2550602693 hasAuthorship W2550602693A5062217593 @default.
• W2550602693 hasAuthorship W2550602693A5065743027 @default.
• W2550602693 hasAuthorship W2550602693A5087900103 @default.
• W2550602693 hasAuthorship W2550602693A5089308610 @default.
• W2550602693 hasAuthorship W2550602693A5091562783 @default.
• W2550602693 hasConcept C126322002 @default.
• W2550602693 hasConcept C144594695 @default.
• W2550602693 hasConcept C159973064 @default.
• W2550602693 hasConcept C185592680 @default.
• W2550602693 hasConcept C186738567 @default.
• W2550602693 hasConcept C2777292125 @default.
• W2550602693 hasConcept C2777444498 @default.
• W2550602693 hasConcept C2777557582 @default.
• W2550602693 hasConcept C2778261982 @default.
• W2550602693 hasConcept C2778382381 @default.
• W2550602693 hasConcept C2779026020 @default.
• W2550602693 hasConcept C2781287897 @default.
• W2550602693 hasConcept C2781318281 @default.
• W2550602693 hasConcept C2910886357 @default.
• W2550602693 hasConcept C3018697912 @default.
• W2550602693 hasConcept C55493867 @default.
• W2550602693 hasConcept C71924100 @default.
• W2550602693 hasConcept C89560881 @default.
• W2550602693 hasConceptScore W2550602693C126322002 @default.
• W2550602693 hasConceptScore W2550602693C144594695 @default.
• W2550602693 hasConceptScore W2550602693C159973064 @default.
• W2550602693 hasConceptScore W2550602693C185592680 @default.
• W2550602693 hasConceptScore W2550602693C186738567 @default.
• W2550602693 hasConceptScore W2550602693C2777292125 @default.
• W2550602693 hasConceptScore W2550602693C2777444498 @default.
• W2550602693 hasConceptScore W2550602693C2777557582 @default.
• W2550602693 hasConceptScore W2550602693C2778261982 @default.
• W2550602693 hasConceptScore W2550602693C2778382381 @default.
• W2550602693 hasConceptScore W2550602693C2779026020 @default.
• W2550602693 hasConceptScore W2550602693C2781287897 @default.
• W2550602693 hasConceptScore W2550602693C2781318281 @default.
• W2550602693 hasConceptScore W2550602693C2910886357 @default.
• W2550602693 hasConceptScore W2550602693C3018697912 @default.
• W2550602693 hasConceptScore W2550602693C55493867 @default.
• W2550602693 hasConceptScore W2550602693C71924100 @default.
• W2550602693 hasConceptScore W2550602693C89560881 @default.
• W2550602693 hasLocation W25506026931 @default.
• W2550602693 hasOpenAccess W2550602693 @default.
• W2550602693 hasPrimaryLocation W25506026931 @default.
• W2550602693 hasRelatedWork W1489758714 @default.
• W2550602693 hasRelatedWork W1571397203 @default.
• W2550602693 hasRelatedWork W1577204124 @default.
• W2550602693 hasRelatedWork W1969807449 @default.
• W2550602693 hasRelatedWork W1996962111 @default.
• W2550602693 hasRelatedWork W2026217387 @default.
• W2550602693 hasRelatedWork W2035347367 @default.
• W2550602693 hasRelatedWork W2046997719 @default.
• W2550602693 hasRelatedWork W2047871701 @default.
• W2550602693 hasRelatedWork W2049577793 @default.
• W2550602693 hasRelatedWork W2063326408 @default.
• W2550602693 hasRelatedWork W2129730153 @default.
• W2550602693 hasRelatedWork W2404760453 @default.
• W2550602693 hasRelatedWork W2408425951 @default.
• W2550602693 hasRelatedWork W2410794284 @default.
• W2550602693 hasRelatedWork W2492340844 @default.
• W2550602693 hasRelatedWork W2565504584 @default.
• W2550602693 hasRelatedWork W2587047671 @default.
• W2550602693 hasRelatedWork W2594025903 @default.
• W2550602693 hasRelatedWork W2598013422 @default.
• W2550602693 isParatext "false" @default.
• W2550602693 isRetracted "false" @default.
• W2550602693 magId "2550602693" @default.
• W2550602693 workType "article" @default.